At the Winter Clinical Dermatology Meeting, April W. Armstrong, MD, MPH, professor and chief of dermatology at the UCLA ...

The US Food and Drug Administration (FDA) has accepted a supplemental New Drug Application for topical roflumilast, 0.05%, for the treatment of mild to moderate atopic dermatitis (AD) in children aged ...

The human monoclonal antibody known as tralokinumab-ldrm was tested and approved as a safe, effective treatment for pediatric patients with atopic dermatitis aged 12 to 17 years old. Originally ...

TARRYTOWN, N.Y. and PARIS, June 07, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (REGN) and Sanofi today presented results from the DISCOVER Phase 4, single-arm, open-label trial assessing ...

A regulatory decision is expected in the fourth quarter of 2024. The Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) for tapinarof cream, 1% for the ...

Atopic dermatitis flares can cause skin cracks and bleeding. Learn how to care for the wounds and spot signs of infection.

Atopic dermatitis is a chronic (long-lasting) skin condition that causes dry, itchy patches of skin that may crack or ooze. It is the most common form of eczema. Itchiness occurs when an overactive ...

If you’re struggling with dry skin this winter, we know it can feel like an uphill battle to keep your skin moisturized. Throw dermatitis into the mix, and the frustration compounds. No one wants to ...